An Economic Analysis of Transjugular Intrahepatic Portosystemic Covered Stent Shunt for Variceal Bleeding and Refractory Ascites in a Spanish Setting
ConclusionsTIPSS is likely to be a cost-effective and a cost-saving treatment in patients with cirrhosis in indications 1 and 2, compared with standard treatments. The analyses estimate clinical benefits along with reduced healthcare costs from avoided downstream resource consumption.
Source: Advances in Therapy - Category: Drugs & Pharmacology Source Type: research
More News: Bleeding | Cirrhosis | Drugs & Pharmacology | Healthcare Costs | Paracentesis | Spain Health